TOPEKA, Kan. (AP) The Kansas Bioscience Authority’s investment committee approved just under $2 million in new investments.
The investments approved Monday come after Gov. Sam Brownback withheld part of KBA’s annual appropriation of $35 million. KBA leaders say they had plenty of money available to fund the investments.
The Lawrence Journal-World reports the committee approved just under $191,000 for Mencuro Therapeutics Inc. in Lawrence, which develop drugs that are an alternative to morphine for pain management.
Other investments must still be approved by the KBA’s full board during its March 6 meeting.
They include $350,000 for the Center for Animal Health Innovation in Olathe; about $75,000 for Aptakon, based in Kansas City, Kan.; and a $1.3 million research and development award for Aratana Therapeutics, based in Kansas City, Kan.
